
Merck KGaA
MKKGY | OTC
$30.39
+$0.64 (+2.15%)
At close: Sep 21, 2026, 3:54 PM ET
$30.39
$0 (0.00%)
After-hours:
Sep 21, 2026, 4:00 PM ET
Fiscal Year Period Ending | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 | FY 2019 Dec 30, 2019 |
|---|---|---|---|---|---|---|
Revenue | 21.16B | 20.99B | 22.23B | 19.69B | 17.53B | 16.15B |
Cost of Revenue | 8.67B | 8.6B | 8.53B | 7.35B | 6.84B | 6.01B |
Gross Profit | 12.49B | 12.39B | 13.71B | 12.34B | 10.7B | 10.15B |
Operating Income | 3.65B | 3.61B | 4.47B | 4.18B | 2.99B | 2.12B |
Interest Income | 164M | 121M | 72.52M | 54.37M | 39M | 66M |
Pretax Income | 3.54B | 3.48B | 4.29B | 3.92B | 2.63B | 1.74B |
Net Income | 2.78B | 2.82B | 3.33B | 3.06B | 1.99B | 1.32B |
Selling & General & Admin | 5.36B | 5.33B | 5.4B | 4.96B | 4.76B | 4.81B |
Research & Development | 2.28B | 2.45B | 2.52B | 2.41B | 2.29B | 2.27B |
Other Expenses | 1.2B | 1.01B | 1.03B | 777M | 841M | 767M |
Operating Expenses | 8.84B | 8.78B | 8.95B | 8.14B | 7.89B | 7.84B |
Interest Expense | 292M | 272M | 203.89M | 288.4M | 387M | 476M |
Selling & Marketing Expenses | 3.97B | 3.91B | 4.1B | 3.71B | 3.57B | 3.65B |
Cost & Expenses | 17.51B | 17.38B | 17.48B | 15.49B | 14.72B | 13.85B |
Income Tax Expense | 751M | 650M | 948M | 859M | 637M | 440M |
Shares Outstanding (Basic) | 2.17B | 2.18B | 2.17B | 2.17B | 2.17B | 2.17B |
Shares Outstanding (Diluted) | 2.17B | 2.17B | 2.17B | 2.17B | 2.17B | 2.17B |
EPS (Basic) | 1.28 | 1.30 | 1.53 | 1.41 | 0.91 | 0.61 |
EPS (Diluted) | 1.28 | 1.30 | 1.53 | 1.41 | 0.91 | 0.61 |
EBITDA | 5.96B | 5.69B | 6.28B | 5.88B | 4.78B | 4.12B |
EBIT | 3.83B | 3.81B | 4.48B | 4.17B | 3.02B | 2.21B |
Depreciation & Amortization | 2.13B | 1.88B | 1.8B | 1.71B | 1.76B | 1.91B |
Add to Watchlist
Select watchlists to add or remove MKKGY